PEAK6 Investments’s Guardant Health GH Stock Holding History

PEAK6 Investments’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-5,998	Closed	-$215K	–	4232
2023 Q2	$215K	Buy	+5,998	New	+$172K	﹤0.01%	2832
2023 Q1	–	Sell	-14,662	Closed	-$399K	–	4532
2022 Q4	$399K	Buy	+14,662	New	+$671K	﹤0.01%	2718
2022 Q3	–	Sell	-5,998	Closed	-$308K	–	5169
2022 Q2	$215K	Buy	+5,998	New	+$297K	﹤0.01%	2833
2022 Q1	–	Sell	-7,901	Closed	-$541K	–	5472
2021 Q4	$790K	Buy	+7,901	New	+$817K	﹤0.01%	2775
2021 Q1	–	Sell	-2	Closed	-$302	–	5079
2020 Q4	$0	Sell	2 -120	-98%	-$13.8K	﹤0.01%	4782
2020 Q3	$14K	Sell	122 -394	-76%	-$36K	﹤0.01%	4158
2020 Q2	$42K	Sell	516 -1,858	-78%	-$150K	﹤0.01%	4056
2020 Q1	$165K	Sell	2,374 -8,157	-77%	-$626K	﹤0.01%	2999
2019 Q4	$823K	Sell	10,531 -30,614	-74%	-$2.21M	﹤0.01%	1649
2019 Q3	$2.63M	Buy	41,145 +34,485	+518%	+$3.04M	0.02%	1102
2019 Q2	$575K	Buy	+6,660	New	+$509K	﹤0.01%	2156

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

PEAK6 Investments's GH Position: Q3 2023 in Review

PEAK6 Investments sold out of Guardant Health (GH) in Q3 2023, closing a stake of 5,998 shares — an estimated $215K sold.

PEAK6 Investments first reported a position in GH in Q2 2019 and held it in 11 quarters. The position peaked at $2.63M in Q3 2019. 296 funds tracked by Wall St. Rank hold GH as of Q3 2023.

PEAK6 Investments reported no remaining Guardant Health position as of Q3 2023 after selling out during the quarter.
PEAK6 Investments sold 5,998 Guardant Health shares in Q3 2023, an estimated $215K.
PEAK6 Investments first reported a position in Guardant Health in Q2 2019 and held it in 11 quarters.
PEAK6 Investments's Guardant Health position peaked at $2.63M in Q3 2019.
296 funds tracked by Wall St. Rank held Guardant Health as of Q3 2023.

Based on PEAK6 Investments's 13F filing for Q3 2023, filed 13 Nov 2023.